Skip to content
Opens in a new window
Opens an external site
Opens an external site in a new window
Hide This Site
Menu
Voices of Harm Reduction
Meet Our Networks
Explore Resources
Resource Library
The Connecting Guide
The Connecting Guide (English)
Le guide Parlons-en! (Français)
Connections for People Who Use Drugs
Overdose Response with Naloxone
About Us
About OHRN
Updates
Land Acknowledgement
ONLINE LEARNING
Contact Us
Click to visit the OHRN Facebook Account
opens in a new window
Click to visit the OHRN YouTube Account
opens in a new window
ONLINE LEARNING
Contact
Hide This Site
GO
Voices of Harm Reduction
Meet Our Networks
Explore Resources
Resource Library
The Connecting Guide
The Connecting Guide (English)
Le guide Parlons-en! (Français)
Connections for People Who Use Drugs
Overdose Response with Naloxone
About Us
About OHRN
Updates
Land Acknowledgement
Drug:
Psychedelics
Research, Reports & Media
,
Evidence Brief: Novel Non-Fentanyl Synthetic Opioids: Risk Assessment and Implications for Practice
October 28, 2021
Research, Reports & Media
,
Cannabis for depression: How Forbes got it wrong
August 16, 2021
Organizations, Initiatives & Services
,
Research, Reports & Media
,
Drug Analysis Service (January to March 2021) – PHAC
June 8, 2021
Research, Reports & Media
,
Recommendations on Alternatives to Criminal Penalties for Simple Possession of Controlled Substances
May 6, 2021
Education & Training
,
Microdosing Psychedelics: The Curse of Studies Doomed to Being Uninformative
January 20, 2021
Education & Training
,
Multimedia Formats
,
Research, Reports & Media
,
The Drug Science Podcast
July 29, 2019
Load More
Research, Reports & Media